Literature DB >> 20008675

Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system.

Heinrich E Lob1, Paul J Marvar, Tomasz J Guzik, Shraya Sharma, Louise A McCann, Cornelia Weyand, Frank J Gordon, David G Harrison.   

Abstract

The circumventricular organs (CVOs) lack a well-formed blood-brain barrier and produce superoxide in response to angiotensin II and other hypertensive stimuli. This increase in central superoxide has been implicated in the regulation of blood pressure. The extracellular superoxide dismutase (SOD3) is highly expressed in cells associated with CVOs and particularly with tanycytes lining this region. To understand the role of SOD3 in the CVOs in blood pressure regulation, we performed intracerebroventricular injection an adenovirus encoding Cre-recombinase (5x10(8) particles per milliliter) in mice with loxP sites flanking the SOD3 coding region (SOD3(loxp/loxp) mice). An adenovirus encoding red-fluorescent protein was injected as a control. Deletion of CVO SOD3 increased baseline blood pressure modestly and markedly augmented the hypertensive response to low-dose angiotensin II (140 ng/kg per day), whereas intracerebroventricular injection of adenovirus encoding red-fluorescent protein had minimal effects on these parameters. Adenovirus encoding Cre-recombinase-treated mice exhibited increased sympathetic modulation of heart rate and blood pressure variability, increased vascular superoxide production, and T-cell activation as characterized by increased circulating CD69(+)/CD3(+) cells. Deletion of CVO SOD3 also markedly increased vascular T-cell and leukocyte infiltration caused by angiotensin II. We conclude that SOD3 in the CVO plays a critical role in the regulation of blood pressure, and its loss promotes T-cell activation and vascular inflammation, in part by modulating sympathetic outflow. These findings provide insight into how central signals produce vascular inflammation in response to hypertensive stimuli, such as angiotensin II.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008675      PMCID: PMC2813894          DOI: 10.1161/HYPERTENSIONAHA.109.142646

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  34 in total

Review 1.  Superoxide dismutases.

Authors:  W Beyer; J Imlay; I Fridovich
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1991

2.  Double-negative (CD4- CD8-) T cells with an alpha/beta T cell receptor. Non-MHC-restricted cytolytic activity and lymphokine production.

Authors:  E G Brooks; D P Wirt; R M Goldblum; S Vaidya; M T Asuncion; J C Patterson; C F Ware; G R Klimpel
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

Review 3.  Central nervous system and mechanisms of hypertension.

Authors:  M J Brody
Journal:  Clin Physiol Biochem       Date:  1988

Review 4.  Angiotensin and CNS regulation of blood pressure.

Authors:  K L Barnes; C M Ferrario
Journal:  Clin Exp Hypertens       Date:  1980       Impact factor: 1.749

5.  Inotropic action of hydroxylated chlorpromazine metabolites and related compounds.

Authors:  T Akera; D D Ku; T M Brody; A A Manian
Journal:  Biochem Pharmacol       Date:  1978-03-15       Impact factor: 5.858

6.  Peroxynitrite reversibly inhibits Ca(2+)-activated K(+) channels in rat cerebral artery smooth muscle cells.

Authors:  A K Brzezinska; D Gebremedhin; W M Chilian; B Kalyanaraman; S J Elliott
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

7.  Effect of lesions of the anteroventral third ventricle (AV3V) on the development of hypertension in spontaneously hypertensive rats.

Authors:  F J Gordon; J R Haywood; M J Brody; A K Johnson
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

8.  Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.

Authors:  Matthew C Zimmerman; Eric Lazartigues; Ram V Sharma; Robin L Davisson
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

9.  Does superoxide underlie the pathogenesis of hypertension?

Authors:  K Nakazono; N Watanabe; K Matsuno; J Sasaki; T Sato; M Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

Review 10.  Extracellular thiols and thiol/disulfide redox in metabolism.

Authors:  Siobhan E Moriarty-Craige; Dean P Jones
Journal:  Annu Rev Nutr       Date:  2004       Impact factor: 11.848

View more
  85 in total

Review 1.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

2.  CrossTalk opposing view: Most cardiovascular diseases in sleep apnoea are not caused by sympathetic activation.

Authors:  Lena Lavie; Peretz Lavie
Journal:  J Physiol       Date:  2012-06-15       Impact factor: 5.182

Review 3.  The central nervous system and inflammation in hypertension.

Authors:  Paul J Marvar; Heinrich Lob; Antony Vinh; Faresa Zarreen; David G Harrison
Journal:  Curr Opin Pharmacol       Date:  2010-12-31       Impact factor: 5.547

4.  Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury.

Authors:  Markus P Schneider; Jennifer C Sullivan; Paul F Wach; Erika I Boesen; Tatsuo Yamamoto; Tohru Fukai; David G Harrison; David M Pollock; Jennifer S Pollock
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

5.  Reactive oxygen species, NADPH oxidases, and hypertension.

Authors:  Srinivasa Raju Datla; Kathy K Griendling
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

Review 6.  The immune system in hypertension.

Authors:  Daniel W Trott; David G Harrison
Journal:  Adv Physiol Educ       Date:  2014-03       Impact factor: 2.288

Review 7.  The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension.

Authors:  David G Harrison
Journal:  J Am Soc Hypertens       Date:  2013 Jan-Feb

Review 8.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 9.  Sex-specific immune modulation of primary hypertension.

Authors:  Kathryn Sandberg; Hong Ji; Meredith Hay
Journal:  Cell Immunol       Date:  2014-12-08       Impact factor: 4.868

10.  Angiotensin II, oxidant signaling, and hypertension: down to a T?

Authors:  Robin L Davisson; Matthew C Zimmerman
Journal:  Hypertension       Date:  2009-12-14       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.